26 4 differ between these two cases if you normalize to the same air dose between the laboratory exposure and the field 3 exposure, 4 DR, BUGHER: Do you think with your gamma spectro- metry you will come out withsome sort d@estimate here? DR. SONDHAUS: Alderson Reporting Company Washington, D. C q DR. BUGHER: We are not only uncertain as to 150 r; we do not say that the 9 individual's bone marrow or organs or spleens got such 10 radiation; 11 to be before we do come out with a pretty firm estimate? 12 is that right? DR. BOND: How long do you think it is going I think before te final report, Dr. 13 Bugher, we are working with it on our x-ray machines, and 144 the cobalt source that is ideal for solving this problem, and 15 it will probably be sohed before the final report is in. DR. BUGHER: Obviously it is a very important 17 figure to 18 a very helpful comment. 19 have, and as precise as may be possible. That is Are there any other comments or questions to ask 20 of this committee? 21 report by Dr. Bond on te clinical aspects which include the 22 hematologic things, as well. If not, we pass to the second group 23 HEMATOLOGIC, SKIN, AND GENERAL CLINICAL STUDY 24 DR. BOND: Department of Energy Historian's Gi io3 That is the essential thing. g 16 ARC That is quite possible, I think. 1 I think perhaps we had less uncertainties in our material then the dose group. Obviously the dosage | oat iT: Riese d 2")